Comparative safety of dipeptidyl peptidase-4 inhibitors and sulfonylureas among frail older adults.
Andrew R ZulloRobert J SmithRoee GutmanBianca KohlerMatthew S DupreySarah D BerryMedha N MunshiDavid D DorePublished in: Journal of the American Geriatrics Society (2021)
DPP4Is should be a preferred treatment option over SUs for NH residents and other frail older adults given the importance of avoiding hypoglycemia.